J. H. Fuller

3.8k total citations · 2 hit papers
29 papers, 2.9k citations indexed

About

J. H. Fuller is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, J. H. Fuller has authored 29 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in J. H. Fuller's work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diet and metabolism studies (5 papers) and Diabetes Management and Research (5 papers). J. H. Fuller is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diet and metabolism studies (5 papers) and Diabetes Management and Research (5 papers). J. H. Fuller collaborates with scholars based in United Kingdom, United States and Germany. J. H. Fuller's co-authors include H. Keen, R. J. Jarrett, Lynda Stevens, N. J. Morrish, M Shipley, G Rose, F. A. Miles, Margaret McCartney, R. J. Jarrett and Ranjan Chakrabarti and has published in prestigious journals such as Science, The Lancet and Diabetes.

In The Last Decade

J. H. Fuller

29 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

2001 950 citations N. J. Morrish, Lynda Stevens et al. Diabetologia profile →
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

1983 510 citations J. H. Fuller, M Shipley et al. BMJ profile →

Peers

Countries citing papers authored by J. H. Fuller

Since Specialization

Citations

This map shows the geographic impact of J. H. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Fuller more than expected).

Fields of papers citing papers by J. H. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Fuller. The network helps show where J. H. Fuller may publish in the future.

Co-authorship network of co-authors of J. H. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of J. H. Fuller. A scholar is included among the top collaborators of J. H. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. H. Fuller. J. H. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications study 2015 ·European Journal of Clinical Nutrition ·(unknown), Danielle Schoenaker, Gita D. Mishra, M. Toeller, Nish Chaturvedi, J. H. Fuller, Sabita S. Soedamah‐Muthu, (unknown)	18
2	The Concomitants of Raised Blood Sugar: Studies in Newly-Detected Hyperglycaemics 2013 ·International Journal of Epidemiology ·H. Keen, C. Chlouverakis, J. H. Fuller, (unknown)	13
3	Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus (Withdrawn Paper) 1997, art. no. CD002188) 2005 ·UCL Discovery (University College London) ·J. H. Fuller, (unknown), Nish Chaturvedi, (unknown)	6
4	Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes 2001 ·Diabetologia ·(unknown), P. H. Bennett, E. T. Lee, (unknown), H. Keen, J. H. Fuller	29
5	Mortality and causes of death in the WHO multinational study of vascular disease in diabetes breakdown → 2001 ·Diabetologia ·(unknown), N. J. Morrish, (unknown), Lynda Stevens, J. H. Fuller, H. Keen	950
6	The EURODIAB Prospective Complications Study Group. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes 2001 ·Nish Chaturvedi, J. H. Fuller, Marja‐Riitta Taskinen, Giuseppe Penno, Roberto Miccoli, Monica Nannipieri, Samantha Manfredi	24
7	Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity 2001 ·Diabetologia ·(unknown), E. T. Lee, H. Keen, P. H. Bennett, J. H. Fuller, Minjie Lu	92
8	Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes 2001 ·Diabetologia ·(unknown), Helen M. Colhoun, E. T. Lee, (unknown), Minjie Lu, H. Keen, S-L Wang, Lynda Stevens, J. H. Fuller	71
9	Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study 2000 ·Diabetologia ·B. Karamanos, Massimo Porta, Marco Songini, Željko Metelko, Z Kerényi, Gy. Tamás, (unknown), L. K. Stevens, J. H. Fuller	45
10	Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients 2000 ·Diabetologia ·(unknown), Helen M. Colhoun, Marja‐Riitta Taskinen, Barbara Idzior−Waluś, J. H. Fuller	21
11	Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study Group. 1999 ·PubMed ·M. Toeller, Anette E. Buyken, G. Heitkamp, Giovanni De Pergola, Francesco Giorgino, J. H. Fuller	30
12	Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. breakdown → 1983 ·BMJ ·J. H. Fuller, M Shipley, G Rose, R. J. Jarrett, H. Keen	510
13	Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: A multinational study 1982 ·Diabetologia ·Kelly M West, M. M. S. Ahuja, P. H. Bennett, B. Grab, (unknown), (unknown), J. H. Fuller, R. J. Jarrett, H. Keen, Kinori Kosáka, A. S. Krolewski, (unknown), V Schliack, A Teuscher	57
14	Hyperglycemia and Arterial Disease 1981 ·Diabetes ·H. Keen, R. J. Jarrett, J. H. Fuller, Peter McCartney	35
15	Haemostatic variables associated with diabetes and its complications. 1979 ·BMJ ·J. H. Fuller, H. Keen, R. J. Jarrett, (unknown), T W Meade, Ranjan Chakrabarti, W. R. S. North, Yvonne Stirling	234
16	Worsening to diabetes in men with impaired glucose tolerance (?borderline diabetes?) 1979 ·Diabetologia ·R. J. Jarrett, H. Keen, J. H. Fuller, Margaret McCartney	150
17	Glucose Tolerance and Blood Pressure in Two Population Samples: Their Relation to Diabetes Mellitus and Hypertension 1978 ·International Journal of Epidemiology ·R. J. Jarrett, H. Keen, Margaret McCartney, J. H. Fuller, P. J. Hamilton, D. D. Reid, George A. Rose	162
18	Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin. 1977 ·BMJ ·R. J. Jarrett, H. Keen, J. H. Fuller, Margaret McCartney	30
19	ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS 1975 ·The Lancet ·H. Keen, R. J. Jarrett, J. H. Fuller	1
20	Visual Tracking and the Primate Flocculus 1975 ·Science ·F. A. Miles, J. H. Fuller	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact